Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × romiplostim × 30 days × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1

Interventions

Temozolomide 7 Vincristine 5 Irinotecan 5 Cyclophosphamide 4 Etoposide 3 etoposide phosphate 2 cabozantinib 2 abemaciclib 2 Ifosfamide 2 Doxorubicin 2 silmitasertib 1 romiplostim 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 liposomal doxorubicin 1 ganitumab 1 fludarabine 1 dinutuximab 1 Zoledronic Acid 1 X-Rays 1 Whole-Body Irradiation 1 Weight-Bearing 1 Topotecan 1 Tacrolimus 1 Specimen Handling 1 Sirolimus 1 Range of Motion, Articular 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07048249 2026-03-18

Single Arm Romiplostim to Prevent CIT

Children's Hospital Medical Center, Cincinnati

Phase EARLY_PHASE1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡